| Date | Title | | | 12/15/09 | BioMed Realty Trust Declares Fourth Quarter 2009 Common Stock and Preferred Stock Dividends| SAN DIEGO, Dec 15, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a fourth quarter 2009 dividend of $0.14 per share of common stock, representing a 27.3% increase over the company's third quarter 2009 dividend of $0.11 per share. The dividend is equivalent to an annualized dividend of $0.56 per common share.
BioMed also announced that its board of directors has declared a dividend of $0.46094 per share of... |
|  | | 12/09/09 | BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes| SAN DIEGO, Dec 09, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the expiration and final results of the previously announced cash tender offer by its operating partnership, BioMed Realty, L.P., for any and all of its outstanding 4.50% Exchangeable Senior Notes due 2026 (the "Notes").
As of midnight, New York City time, on Tuesday, December 8, 2009, the scheduled expiration date of the tender offer, $61,270,000.00 in aggregate principal amount o... |
| | | 12/07/09 | BioMed Realty Trust Expands Unsecured Line of Credit to $720 Million|
SAN DIEGO, Dec. 7 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has increased the borrowing capacity on its unsecured line of credit by an additional $55 million. With the $65 million increase in availability announced last month, BioMed has raised the aggregate capacity under its unsecured line of credit by $120 million to $720 million, with no other material changes to the terms of the facility.
Kent Griffin, BioMed's President and... |
| | | 12/03/09 | BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark|
SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) for approximately 131,000 square feet of additional, newly-constructed laboratory and office space at The Landmark at Eastview campus in Tarrytown, New York. The new lease expires on June 30, 2023. This lease of additional space was completed approximately two months after BioMed and Regeneron celebrated t... |
| | | 11/09/09 | BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million|
SAN DIEGO, Nov. 9 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has received commitments from lenders to increase the borrowing capacity on its unsecured line of credit by $65 million to an aggregate of $665 million, with no other changes to the terms of the facility. The weighted-average effective interest rate of the unsecured line of credit was 1.35% as of September 30, 2009. The maturity date remains August 1, 2011, which may be exten... |
| | | 11/09/09 | BioMed Realty Commences Tender Offer for Its Exchangeable Notes|
SAN DIEGO, Nov. 9 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its operating partnership, BioMed Realty, L.P., has commenced a cash tender offer for any and all of its outstanding 4.50% Exchangeable Senior Notes due 2026 (the "Notes"). Currently, $107,420,000 aggregate principal amount of the Notes is outstanding. The terms and conditions are set forth in the offer to purchase and related letter of transmittal, each dated November 9, 2009.
Pursua... |
| | | 10/29/09 | BioMed Realty Trust Extends Lease at Landmark With Progenics Pharmaceuticals|
SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that it has entered into a new ten-year lease with Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) encompassing approximately 148,000 square feet at The Landmark at Eastview campus in Tarrytown, New York. This new lease replaces existing leases with Progenics which were set to expire from 2009 to 2012.
(Logo: http://www.newscom.com/cgi-bin/prnh/20091005/BIOMEDLOGO)
According to Alan D. Go... |
| | | 10/28/09 | BioMed Realty Trust Announces 80,000 Square Foot Lease in Cambridge With the Broad Institute|
SAN DIEGO, Oct. 28 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the signing of a new lease at its 301 Binney Street laboratory research facility in Cambridge, Massachusetts. The world-renowned Broad Institute of MIT and Harvard agreed to a ten-year lease for approximately 80,000 square feet in the heart of Cambridge's biotechnology super-cluster. The five-story, state-of-the-art 301 Binney Street research facility is owned through the company's joint vent... |
| | | 10/28/09 | BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results| SAN DIEGO, Oct 28, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry(R), today announced operating and financial results for the third quarter ended September 30, 2009.
(Logo: http://www.newscom.com/cgi-bin/prnh/20091005/BIOMEDLOGO)
Highlights:
Increased total revenues for the third quarter to $93.0 million, up
15.1% from $80.8 million for the same ... |
| | | 10/15/09 | BioMed Realty Trust to Report 2009 Third Quarter Results|
SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its third quarter ended September 30, 2009 after the market closes on Wednesday, October 28, 2009.
(Logo: http://www.newscom.com/cgi-bin/prnh/20091005/BIOMEDLOGO)
Alan D. Gold, Chairman and Chief Executive Officer, and Kent Griffin, President and Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, ... |
| | | 10/06/09 | Regeneron Pharmaceuticals and BioMed Realty Trust Host Ribbon-Cutting Ceremony at the Landmark at Eastview| Two New Buildings Serve as Regeneron's Corporate Headquarters and Research Facility
TARRYTOWN, N.Y., Oct. 6 /PRNewswire-FirstCall/ -- State, county and local government leaders today joined senior management from Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and BioMed Realty Trust, Inc. (NYSE: BMR) to celebrate the completion of Regeneron's new 229,000 square foot corporate headquarters and research facility at BioMed's The Landmark at Eastview campus in Tarrytown, New York. Featu... |
| | | 09/15/09 | BioMed Realty Trust Declares Third Quarter 2009 Common Stock and Preferred Stock Dividends|
SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a third quarter 2009 dividend of $0.11 per share of common stock. The dividend is equivalent to an annualized dividend of $0.44 per common share.
BioMed also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from July 16, 2009 thr... |
| | | 08/06/09 | BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company| Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR), The Leading Provider of Real Estate to the Life Science Industry®
, announced today that its board of directors and corporate officers will ring
The Closing Bell at the New York Stock Exchange on Thursday, August 6, 2009
at 4:00 p.m. Eastern Time to commemorate the fifth anniversary of the
company's initial public offering. The... |
| | | 07/29/09 | BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results| SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR), a real estate investment trust focused on Providing Real Estate
to the Life Science Industry , today announced operating and financial results
for the second quarter ended June 30, 2009.
Highlights:
Increased total revenues for the second quarter to $86.1 million, up
21.6% from $70.8 million for the same period in 2008, driven primarily
by sustained leasing success and deli... |
| | | 07/22/09 | BioMed Realty Trust To Report 2009 Second Quarter Results| SAN DIEGO, July 22, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its second quarter ended June 30, 2009 after the market closes on Wednesday, July 29, 2009.
Alan D. Gold, Chairman and Chief Executive Officer, and Kent Griffin, President and Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, July 30, 2009 to discuss the company's financial results and operations for t... |
| | | 06/29/09 | BioMed Realty Trust Completes $350 Million Financing for Center for Life Science | Boston| SAN DIEGO, June 29, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the closing of a new $350 million loan with John Hancock Life Insurance Company, TIAA-CREF, and Westdeutsche ImmobilienBank AG. The five year loan is secured by a single property - the Center for Life Science | Boston, a newly constructed 700,000+ square foot state-of-the-art research facility that recently received Gold LEED(R) certification from the U.S. Green Building Council.
... |
| | | 06/22/09 | BioMed Realty Trust Closes New $18 Million Secured Loan| SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) announced today the closing of a new $18 million loan secured by
the company's 9865 Towne Centre Drive property in San Diego.
Construction of 9865 Towne Centre Drive, a state-of-the-art laboratory and
office facility, was completed in the second quarter of 2008, and the building
has since received LEED(R) Silver certification for Core and Shell from the
U.S. Green Building Council. The facility was ... |
| | | 06/15/09 | BioMed Realty Trust Declares Second Quarter 2009 Common Stock and Preferred Stock Dividends| SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) today announced that its board of directors has declared a second
quarter 2009 dividend of $0.11 per share of common stock. The dividend is
equivalent to an annualized dividend of $0.44 per common share.
BioMed also announced that its board of directors has declared a dividend
of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable
Preferred Stock for the period from April 16, 2... |
| | | 05/13/09 | BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock| SAN DIEGO, May 13, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the pricing of its public offering of 16,000,000 shares of its common stock at $10.40 per share. The offering is expected to close on or about May 18, 2009. Gross proceeds from the offering will be approximately $166.4 million. BioMed expects to use the net proceeds of the offering to repay a portion of the outstanding indebtedness under its $600.0 million unsecured line of credi... |
| | | 05/12/09 | BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock| SAN DIEGO, May 12, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has commenced a public offering of 14,000,000 shares of its common stock pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. BioMed expects to use the net proceeds of the offering to repay a portion of the outstanding indebtedness under its $600.0 million unsecured line of credit and for other general corporate and working cap... |
| | | 05/01/09 | BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals| SAN DIEGO, May 1 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) announced today that it has entered into a new 15-year lease with
Regeneron Pharmaceuticals, Inc. encompassing approximately 80,000 square feet
at the Landmark at Eastview campus in Tarrytown, New York, which was
previously leased to Emisphere Technologies, Inc.
Commenting on Regeneron's lease expansion, Alan D. Gold, BioMed's Chairman
and Chief Executive Officer, said, "BioMed has supported Regeneron'... |
| | | 04/29/09 | BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results|
Generates Record $94 Million in Total Revenues for the Quarter
SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry(R), today announced operating and financial results for the first quarter ended March 31, 2009.
Highlights:
Record total revenues for the first quarter were $94.0 million, up 39.5% from $67.4 million for the same period in 2008, dr... |
| | | 04/21/09 | BioMed Realty Trust to Report 2009 First Quarter Results| SAN DIEGO, Apr 21, 2009 (BUSINESS WIRE) -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report
results for its first quarter ended March 31, 2009 after the market
closes on Wednesday, April 29, 2009.
Alan D. Gold, Chairman and Chief Executive Officer, and Kent Griffin,
President and Chief Financial Officer, will host an investor conference
call at 10:00 a.m. Pacific Time on Thursday, April 30, 2009 to discuss
the company's financial resul... |
| | | 04/16/09 | BioMed Realty Trust Launches 2008 Annual Report Online| SAN DIEGO, April 16, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that its 2008 Online Annual Report and other proxy materials are now available at www.biomedrealty.com/08ar. Entitled "Built to Thrive," the online annual report is designed to more actively and effectively communicate BioMed's business strategy and operating and financial results for 2008 by utilizing a state-of-the-art interface design, with a combination of video and textual c... |
| | | 04/02/09 | BioMed Realty Trust Receives LEED(R) Gold Certification at Center for Life Science | Boston| SAN DIEGO, April 2 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR), The Leading Provider of Environmentally Sustainable Real Estate
to the Life Science Industry(R), announced today that the world's leading life
science research center - the Center for Life Science | Boston in the Longwood
Medical Area - has achieved Gold LEED(R) certification for Core and Shell from
the U.S. Green Building Council (USGBC). The property is 91% leased to Beth
Israel Deaconess Medical Cen... |
| | | 03/16/09 | BioMed Realty Trust Declares First Quarter 2009 Common Stock and Preferred Stock Dividends| SAN DIEGO, March 16 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) today announced that its board of directors has declared a first
quarter 2009 dividend of $0.335 per share of common stock. The dividend is
equivalent to an annualized dividend of $1.34 per common share.
BioMed also announced that its board of directors has declared a dividend
of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable
Preferred Stock for the period from January 16... |
| | | 03/02/09 | BioMed Realty Trust to Present at Citi 2009 Global Property CEO Conference| SAN DIEGO, March 2, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at the Citi 2009 Global Property CEO Conference in Naples, Florida at approximately 9:05 a.m. Eastern Standard Time on Wednesday, March 4, 2009.
The presentation will be open to all investors by calling 719.785.5595 and providing the passcode 348395.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate inv... |
| | | 02/11/09 | BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors| SAN DIEGO, Feb. 11 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) announced today the completion of a refinancing of the secured
acquisition and interim loan facility originally entered into in April 2007 by
its joint venture with a fund managed by Prudential Real Estate Investors to
acquire, among other properties, approximately 600,000 square feet of life
science space in Cambridge, Massachusetts.
Proceeds from the refinancing were approximately $203 million, and... |
| | | 02/11/09 | BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results| SAN DIEGO, Feb. 11 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR), a real estate investment trust focused on Providing Real Estate
to the Life Science Industry(R), today announced financial results for the
fourth quarter and full-year ended December 31, 2008.
Fourth Quarter 2008 Highlights
The company significantly de-leveraged during the quarter, reducing
the percentage of debt to total assets to 41.8%, the company's lowest
level since Septe... |
| | | 02/02/09 | BioMed Realty Trust to Report 2008 Fourth Quarter and Year-End Results| SAN DIEGO, Feb 02, 2009 /PRNewswire-FirstCall via COMTEX/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its fourth quarter and year ended December 31, 2008 after the market closes on Wednesday, February 11, 2009.
Alan D. Gold, Chairman and Chief Executive Officer, and Kent Griffin, President and Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, February 12, 2009 to discuss the company's financial results ... |
| | | 01/30/09 | BioMed Realty Trust Revises Announcement of Tax Treatment of 2008 Distributions| SAN DIEGO, Jan. 30 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) today amended its news release "BioMed Realty Trust Announces Tax
Treatment of 2008 Distributions" issued January 20, 2009 with respect to the
Taxable Ordinary Dividend and Return of Capital distributions for the four
quarterly dividends displayed in the Common Stock table. The amended version
of the distribution tables and information follows:
Security Description: Common Sto... |
| | | 01/20/09 | BioMed Realty Trust's Center for Life Science | Boston Now 91% Leased| SAN DIEGO, Jan. 20 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) announced today the signing of a new lease at the Center for Life
Science | Boston with Kowa Company, Ltd., one of the largest privately owned
companies in Japan. Kowa has agreed to lease the 17th floor, which provides
approximately 24,400 square feet of laboratory and office space. As a result
of this transaction, along with the recently announced lease expansion with
Children's Hospital Boston, the Cen... |
| | | 01/15/09 | BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015| SAN DIEGO, Jan. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR) announced today the signing of two lease extensions in Cambridge,
Massachusetts with Vertex Pharmaceuticals Incorporated, totaling over 292,000
square feet at BioMed's 40 Erie Street (also known as Vertex's Corporate
Headquarters at 130 Waverly Street) and 200 Sidney Street properties. Both
leases now extend through December 31, 2015. In total, Vertex leases
approximately 685,000 square feet at five BioM... |
| |
|
Print | 
E-mail Page | 
RSS Feeds | 
IR Contacts | 
Tear Sheet
